Collegium Pharmaceutical's Efficient Capital Utilization Stands Out in the Pharmaceutical Industry

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) showcases a Return on Invested Capital (ROIC) of 10.34%, significantly outperforming its Weighted Average Cost of Capital (WACC) of 5.18%.Amphastar Pharmaceuticals and Syndax Pharmaceuticals demonstrate lower efficiency in capital utilization compared to Collegium, with Amphastar barely generating returns above its cost of capital.Ironwood Pharmaceuticals exhibits the highest efficiency with a ROIC of 62.21% and a WACC of 6.21%, indicating exceptional capital man ...